Skip to main content
. 2020 Jun 16;20:171. doi: 10.1186/s12890-020-01212-9

Table 1.

Body mass index and lung function of study populations included in the genotype-outcome association analyses

MR step Study N Age (years), median (IQR) BMI (kg/m2), median (IQR) FEV1 (L), median (IQR) FVC (L), median (IQR) FEV1/FVC (%),median (IQR)
1st ECRHS 470 55 (49–60) 26.0 (23.3–29.3) 2.9 (2.4–3.5) 3.8 (3.2–4.6) 76 (72–80)
NFBC1966 681 46 (46–47) 25.8 (23.3–29.1) 3.4 (2.9–4.0) 4.4 (3.8–5.2) 77 (74–81)
SAPALDIA 906 58 (50–68) 25.9 (23.3–29.3) 2.9 (2.4–3.5) 4.0 (3.3–4.8) 74 (69–78)
2nd ECRHS 773 54 (48–60) 26.3 (23.8–29.8) 2.9 (2.5–3.5) 3.9 (3.3–4.7) 76 (72–80)
NFBC1966 4501 47 (46–47) 26.1 (23.5–29.4) 3.3 (2.9–3.9) 4.3 (3.7–5.1) 78 (74–82)
SAPALDIA 2303 60 (50–67) 25.7 (23.1–28.6) 3.0 (2.5–3.6) 4.1 (3.4–4.9) 74 (69–78)
UK Biobank 275,861 58 (50–63) 26.6 (24.1–29.7) 2.7 (2.3–3.3) 3.6 (3.0–4.3) 77 (73–80)

MR Mendelian randomisation. IQR Interquartile range. BMI Body mass index. FEV1 Forced expiratory volume in one second. FVC Forced vital capacity